Interestingly, the effect of VX765 treatment differed in neuronal tumors where elevated levels of CCL11 and CCL26 were found in SH-SY5Y compared to untreated controls (Supplementary Table 4D), and no changes in cytokine levels were detected in VX765 treated U138MG cells compared to controls (Supplementary Table 4E). This evidence concerns the gene CCL11 and neuronal tumor.